|
|
|
|
|
|
|
|
|
Smarter Lead Selection and Faster Representative Material for Early CMC Studies
|
Early CMC decisions have lasting implications for biologic development programs, influencing candidate selection, development timelines, and overall risk. Join us to explore emerging approaches to cell line development and early material generation that may help teams assess biologic candidates sooner, gain more representative data earlier in development, and make informed decisions that support efficient progression toward IND-enabling studies and clinical milestones. Learn more.
|
|
|
|
|
|
Webinar | Abzena
|
Integrated bioconjugate development models reduce technical and operational risk by unifying discovery, analytics, process development, and GMP manufacturing, accelerating ADC and AOC programs from bench to clinic.
|
|
|
|
|
|
Video | KBI Biopharma
|
Combining targeted transposon tech with stable bulk pool generation accelerates cell line development, enabling early material production and fast-tracking candidate selection for clinical entry.
|
|
|
|
|
|
Video | AGC Biologics
|
Scale cell therapies efficiently by adopting automated, closed systems and advanced analytical testing to reduce contamination risks, ensure regulatory compliance, and secure global patient supply.
|
|
|
|
|
|
Webinar | Upperton Pharma Solutions
|
View how spray drying enables stable, precisely engineered pulmonary powders for biologics, supporting efficient lung delivery, scalability, and preservation of molecular structure and activity.
|
|
|
|
|
|
Video | West Pharmaceutical Services, Inc.
|
As a trusted partner to both established and emerging drug developers, we support the safe, effective containment and delivery of life-saving and life-enhancing medicines.
|
|
|
|
|
|
Video | Outsourced Pharma
|
This segment of the Outsourced Pharma Live event, “Charting A Direct Pathway From Academia To CDMOs,” addresses one of the biggest knowledge gaps facing academic research teams: mistaking repeatable laboratory results for a genuine quality control system.
|
|
|
|
|
|
|
|
|
|
Webinar: From IND to Commercial Reality: Scaling Cell and Gene Therapy Manufacturing
|
What does it take to move a cell and gene therapy from development to commercial supply? Join us for a practical conversation on evolving CMC strategies, choosing the right commercialization partner, reducing batch costs, and navigating regulatory challenges. We’ll explore hidden inefficiencies, when to challenge conventional approaches, and how proactive lifecycle planning supports successful commercialization. Click here to learn more.
|
|
|
| Connect With Outsourced Pharma: |
|
|
|
|
